AC927, a σ receptor ligand, blocks methamphetamine-induced release of dopamine and generation of reactive oxygen species in NG108-15 cells
- PMID: 22101517
- PMCID: PMC3286303
- DOI: 10.1124/mol.111.074120
AC927, a σ receptor ligand, blocks methamphetamine-induced release of dopamine and generation of reactive oxygen species in NG108-15 cells
Abstract
Methamphetamine is a highly addictive psychostimulant drug of abuse that causes neurotoxicity with high or repeated dosing. Earlier studies demonstrated the ability of the selective σ receptor ligand N-phenethylpiperidine oxalate (AC927) to attenuate the neurotoxic effects of methamphetamine in vivo. However, the precise mechanisms through which AC927 conveys its protective effects remain to be determined. With the use of differentiated NG108-15 cells as a model system, the effects of methamphetamine on neurotoxic endpoints and mediators such as apoptosis, necrosis, generation of reactive oxygen species (ROS) and reactive nitrogen species (RNS), and dopamine release were examined in the absence and presence of AC927. Methamphetamine at physiologically relevant micromolar concentrations caused apoptosis in NG108-15 cells. At higher concentrations of methamphetamine, necrotic cell death was observed. At earlier time points, methamphetamine caused ROS/RNS generation, which was detected with the fluorigenic substrate 5-(and-6)-chloromethyl-2',7'-dichlorodihydrofluorescin diacetate, acetyl ester, in a concentration- and time-dependent manner. N-Acetylcysteine, catalase, and l-N(G)-monomethyl arginine citrate inhibited the ROS/RNS fluorescence signal induced by methamphetamine, which suggests the formation of hydrogen peroxide and RNS. Exposure to methamphetamine also stimulated the release of dopamine from NG108-15 cells into the culture medium. AC927 attenuated methamphetamine-induced apoptosis, necrosis, ROS/RNS generation, and dopamine release in NG108-15 cells. Together, the data suggest that modulation of σ receptors can mitigate methamphetamine-induced cytotoxicity, ROS/RNS generation, and dopamine release in cultured cells.
Figures






Similar articles
-
Sigma (σ) receptor ligand, AC927 (N-phenethylpiperidine oxalate), attenuates methamphetamine-induced hyperthermia and serotonin damage in mice.Pharmacol Biochem Behav. 2011 Mar;98(1):12-20. doi: 10.1016/j.pbb.2010.11.023. Epub 2010 Dec 2. Pharmacol Biochem Behav. 2011. PMID: 21130800 Free PMC article.
-
Neuroprotective targets through which 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a sigma receptor ligand, mitigates the effects of methamphetamine in vitro.Eur J Pharmacol. 2014 Feb 5;724:193-203. doi: 10.1016/j.ejphar.2013.12.039. Epub 2013 Dec 28. Eur J Pharmacol. 2014. PMID: 24380829 Free PMC article.
-
Attenuation of methamphetamine-induced effects through the antagonism of sigma (sigma) receptors: Evidence from in vivo and in vitro studies.Eur Neuropsychopharmacol. 2008 Dec;18(12):871-81. doi: 10.1016/j.euroneuro.2008.07.006. Epub 2008 Aug 27. Eur Neuropsychopharmacol. 2008. PMID: 18755577 Free PMC article.
-
Could sigma receptor ligands be a treatment for methamphetamine addiction?Curr Drug Abuse Rev. 2010 Sep;3(3):156-62. doi: 10.2174/1874473711003030156. Curr Drug Abuse Rev. 2010. PMID: 21054260 Review.
-
Methamphetamine-induced dopaminergic neurotoxicity: role of peroxynitrite and neuroprotective role of antioxidants and peroxynitrite decomposition catalysts.Ann N Y Acad Sci. 2001 Jun;939:366-80. doi: 10.1111/j.1749-6632.2001.tb03646.x. Ann N Y Acad Sci. 2001. PMID: 11462792 Review.
Cited by
-
SN79, a sigma receptor ligand, blocks methamphetamine-induced microglial activation and cytokine upregulation.Exp Neurol. 2013 Sep;247:134-42. doi: 10.1016/j.expneurol.2013.04.009. Epub 2013 Apr 28. Exp Neurol. 2013. PMID: 23631864 Free PMC article.
-
Ultra-performance liquid chromatography tandem mass spectrometry method for the determination of AZ66, a sigma receptor ligand, in rat plasma and its application to in vivo pharmacokinetics.Biomed Chromatogr. 2013 Aug;27(8):1034-40. doi: 10.1002/bmc.2901. Epub 2013 Apr 5. Biomed Chromatogr. 2013. PMID: 23558564 Free PMC article.
-
Revisiting the sigma-1 receptor as a biological target to treat affective and cognitive disorders.Neurosci Biobehav Rev. 2022 Jan;132:1114-1136. doi: 10.1016/j.neubiorev.2021.10.037. Epub 2021 Nov 1. Neurosci Biobehav Rev. 2022. PMID: 34736882 Free PMC article. Review.
-
Cannabidiol attenuates methamphetamine-induced conditioned place preference via the Sigma1R/AKT/GSK-3β/CREB signaling pathway in rats.Toxicol Res (Camb). 2020 May 9;9(3):202-211. doi: 10.1093/toxres/tfaa021. eCollection 2020 Jun. Toxicol Res (Camb). 2020. PMID: 32670551 Free PMC article.
-
Sigma Receptors and Substance Use Disorders.Adv Exp Med Biol. 2017;964:177-199. doi: 10.1007/978-3-319-50174-1_13. Adv Exp Med Biol. 2017. PMID: 28315272 Free PMC article. Review.
References
-
- Booth RG, Baldessarini RJ. (1991) (+)-6,7-Benzomorphan sigma ligands stimulate dopamine synthesis in rat corpus striatum tissue. Brain Res 557:349–352 - PubMed
-
- Bowen WD. (2000) Sigma receptors: recent advances and new clinical potentials. Pharm Acta Helv 74:211–218 - PubMed
-
- Cadet JL, Brannock C. (1998) Free radicals and the pathobiology of brain dopamine systems. Neurochem Int 32:117–131 - PubMed
-
- Cadet JL, Ordonez SV, Ordonez JV. (1997) Methamphetamine induces apoptosis in immortalized neural cells: protection by the proto-oncogene, bcl-2. Synapse 25:176–184 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical